Did You Know...
...that after Walter Hunt patented the safety pin in 1849, he sold the rights to it for $400?
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7217737 | Method and compositions for inhibiting cell proliferative disorders The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR... | 05/15/2007 |
| 6410588 | Use of cannabinoids as anti-inflammatory agents The application relates to the identification that cannabinoids, such as cannabidiol can be used to treat inflammatory diseases. Cannabinoids for use in treating inflammatory diseases, methods of treating inflammatory diseases and cannabinoids in combinat... | 06/25/2002 |
| 6331416 | Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells A process of expressing a recombinant protein in a plant and of isolating the recombinant protein from the plant, the process is effected by (a) providing a plant, a plant derived tissue or cultured plant cells expressing a fusion protein including the re... | 12/18/2001 |
| 6252141 | Tomato gene B polynucleotides coding for lycopene cyclase An isolated complementary and genomic DNA segment encoding lycopene cyclase of the B locus of tomato are provided.... | 06/26/2001 |
| 6218599 | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a ଲ-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants The present invention relates, in general, to a biotechnological method for production of (3S,3'S) astaxanthin. In particular, the present invention relates to a peptide having a ଲ-C-4-oxygenase activity; a DNA segment coding for this peptide; an RN... | 04/17/2001 |
| 5965795 | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants The present invention relates, in general, to a biotechnological method for production of (3S,3'S) astaxanthin. In particular, the present invention relates to a peptide having a ଲ-C-4-oxygenase activity; a DNA segment coding for this peptide; an RN... | 10/12/1999 |
| 5935808 | Carotenoid-producing bacterial species and process for production of carotenoids using same A novel Paracoccus species type strain DSM 11574 which produces and secretes carotenoids such as ଲ-carotene, echinenone, ଲ-cryptoxanthin, canthaxanthin, adonirubin, cis-adonixanthin, adonixanthin, astaxanthin and zeaxanthin in vesicles; carote... | 08/10/1999 |
| 5932580 | PDGF receptor kinase inhibitory compounds their preparation and compositions PDGF receptor kinase inhibitory compounds of the quinoxaline family, methods for their synthesis and containment is slow release pharmaceutical preparations, and their use for treatment of proliferative malignant and non-malignant diseases or disorders by... | 08/03/1999 |
| 5932602 | Treatment of platelet derived growth factor related disorders such as cancers The present invention concerns compounds which can inhibit platelet derived growth factor receptor (PDGF-R) activity, preferably such compounds also inhibit the activity other members of the PDGF-R super family and are selective for members of the PDGF-R ... | 08/03/1999 |
| 5773476 | Methods and compositions for inhibiting cell proliferative disorders The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HE... | 06/30/1998 |
| 4797285 | Lipsome/anthraquinone drug composition and method A drug/liposome composition comprising an aqueous suspension of liposomes and, entrapped in the lipid bilayer region of the liposomes, an anthraquinone drug containing quinone and hydroquinone functionalities on adjacent anthracene rings. An iron-specific... | 01/10/1989 |
| 4748021 | Antifungal compositions containing trichoderma active against fusarium A biological control agent comprising the antifungal agent Trichoderma harzianum T-35 (ATCC No. 20691), which is characterized by antifungal activity against fungi of the genus Fusarium. This strain is useful for protecting most crops affected by the fung... | 05/31/1988 |
